News

Bayer Schering Pharma’s first Phase II trial with oral agent Riociguat (BAY 63-2521) in pulmonary hypertension, owing to interstitial lung disease (PH-ILD), has successfully been completed. The primary

AdvanDx has received FDA 510(k) clearance for a 90 minutes protocol for its S. aureus PNA FISH and S. aureus/CNS PNA FISH tests. The protocol reduces the PNA

Celgene UK has announced that preliminary clinical data from a phase III, randomized, double-blind study of elderly patients newly diagnosed with multiple myeloma, were presented during the 51st

Genomic Health has reported that The Lancet Oncology has published positive results from a study of Oncotype DX in postmenopausal women with node-positive, estrogen receptor-positive breast cancer. The

Proscape Technologies has reported that one of the largest pharmaceutical companies has deployed its new software platform as the key component of their global sales and marketing strategy.

Perceptive Informatics has launched product convergence between its DataLabs EDC solution and ClinPhone Randomisation and Trial Supply Management (RTSM) technologies. New functionality in the DataLabs EDC solution has

Cumberland Pharmaceuticals (Cumberland) has entered into an exclusive agreement with DB Pharm Korea for the commercialisation of Caldolor (ibuprofen) injection in South Korea. Designed to treat pain and

Atrium Medical has enrolled first patient in the Infuse AMI trial. Infuse AMI is a multi-center, multi-national, prospective, randomised, single blind trial, examining how patients with heart attacks

OvumOptics has introduced Ovu-Trac Ovulation Predictor Kit, which helps women increase their chances of conception, naturally, without medical intervention. The company said that Ovu-Trac kit uses saliva sampling